Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Stephen Garner has worked on the following 27 EPO patent applications which have been published in the last five years:

EP12748087

PURIFIED PROTEINS

IPC classification:
A61K 38/20, B01D 15/36, C07K 14/545
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14164650

Genz 112638 for treating Gaucher or Fabry disease in combination therapy

IPC classification:
A61K 31/4025, A61P 35/00, C07D 405/06
Applicant:
Genzyme Corporation
Agent:
Potter Clarkson LLP
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13804115

COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION

IPC classification:
A61K 9/00, A61K 31/135
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13765893

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
A61K 31/439, A61P 25/00, A61P 35/00, C07D 453/02, C07D 471/08
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13853407

BIOGLASS WITH GLYCOSAMINOGLYCANS

IPC classification:
A61F 13/00, A61K 9/14, A61K 33/04
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13789690

COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES

IPC classification:
A61K 38/46, A61P 25/28
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13811641

IL-6 ANTAGONISTS AND USES THEREOF

IPC classification:
A61P 27/02, C07K 16/24
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13863954

BIOACTIVE GLASS WITH ETHYLENE OXIDE PROPYLENE OXIDE BLOCK COPOLYMERS

IPC classification:
A61F 2/28
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14718835

METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
C07D 277/30, C07D 417/06, C07D 453/02
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14722435

CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY

IPC classification:
A61K 9/00, A61K 38/20, A61K 47/10, A61K 47/26
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14768673

SODIUM CONTAINING SOL-GEL DERIVED BIOACTIVE GLASSES AND USES THEREOF INCLUDING HEMOSTASIS

IPC classification:
C03C 3/078, C08K 9/06
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14772580

COMPOSITIONS AND METHODS FOR MANUFACTURING SOL-GEL DERIVED BIOACTIVE BOROPHOSPHATE GLASSES FOR MEDICAL APPLICATONS

IPC classification:
C03C 3/078, C08K 9/06
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14723554

PIPERAZINE DERIVATIVES AND THEIR USE AS KIT MODULATORS

IPC classification:
A61K 31/517, A61K 31/5377, A61P 17/00, C07D 239/94, C07D 401/12, C07D 403/04, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 487/04
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14718854

SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE

IPC classification:
A61K 31/439, A61P 3/00, A61P 35/00, C07D 453/00
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14733757

ALBUMIN VARIANTS BINDING TO FCRN

IPC classification:
G01N 33/50
Agent:
Stephen Garner, Mathys & Squire LLP
Agent:
Rachel Clare Williams, Novozymes Biopharma UK Limited
Status:
EXAMINATION IN PROGRESS
EP15187794

PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
A61K 31/50
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14799576

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

IPC classification:
A61K 31/53, A61P 35/00, C07D 487/04
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14802532

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

IPC classification:
A61K 31/498, A61P 35/00, C07D 235/30, C07D 401/04, C07D 401/12, C07D 403/12, C07D 403/14, C07D 405/12, C07D 409/12
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14824245

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

IPC classification:
A61K 31/439, A61P 9/00
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15714117

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

IPC classification:
C07K 16/28, C07K 16/32, C07K 16/40, A61K 47/60
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16175117

ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT

IPC classification:
A61K 31/4025, A61K 45/06, A61P 35/00, C07D 405/06
Applicant:
Genzyme Corporation
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15727798

NAMPT INHIBITORS AND METHODS

IPC classification:
A61K 31/438, A61K 31/444, A61K 31/537, A61P 31/12, A61P 35/00, A61P 37/06, C07D 491/107, C07D 491/20, C07D 498/10
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15841528

EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE

IPC classification:
A61K 31/047, A61K 31/135, A61P 21/02
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP15847215

METHODS OF TREATING MUCOPOLYSACCHARIDOSIS IIIB (MPSIIIB)

IPC classification:
A61K 38/47, C12N 9/24
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP17158770

LYSOSOMAL STORAGE DISEASE ENZYME

IPC classification:
A01K 67/027, A61K 31/135, A61K 31/194, A61K 31/366, A61K 31/397, A61K 38/38, A61K 38/46, A61P 3/06, C12N 9/20
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
The application has been published
EP15791424

CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE

IPC classification:
A61K 31/661, A61K 31/6615, A61P 25/16
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made
EP16706041

LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE

IPC classification:
A61K 9/00, A61K 9/10, A61K 31/195, A61K 31/198, A61K 47/38
Applicant:
AbbVie Inc
Agent:
Stephen Garner, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature